Lipe & Dalton Amgen Inc Transaction History

Lipe & Dalton

$186 Million
Q2 2024

A detailed history of Lipe & Dalton transactions in Amgen Inc stock. As of the latest transaction made, Lipe & Dalton holds 9,016 shares of AMGN stock, worth $2.85 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

9,016

Previous 9,356 3.63%

Holding current value

$2.85 Million

Previous $2.66 Million 5.9%

% of portfolio

1.52%

Previous 1.37%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $89,335 - $108,565	-340 Reduced 3.63%	9,016 $2.82 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $18,820 - $22,719	-70 Reduced 0.74%	9,356 $2.66 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $43,925 - $51,940	-205 Reduced 2.13%	9,426 $2.09 Million
Q1 2023 May 02, 2023	SELL	$225.79 - $275.2 $20,321 - $24,768	-90 Reduced 0.93%	9,631 $2.33 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $9,161 - $11,640	40 Added 0.41%	9,721 $2.55 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $10,100 - $11,391	-45 Reduced 0.46%	9,681 $2.18 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $1.29 Million - $1.44 Million	-5,610 Reduced 36.58%	9,726 $2.37 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $2.3 Million - $2.54 Million	10,482 Added 215.95%	15,336 $3.71 Million
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $24,860 - $28,450	-125 Reduced 2.51%	4,854 $1.09 Million
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $160,263 - $187,768	755 Added 17.87%	4,979 $1.06 Million
Q2 2021 Aug 02, 2021	BUY	$233.58 - $259.14 $902,553 - $1 Million	3,864 Added 1073.33%	4,224 $1.03 Million
Q4 2019 Jan 21, 2020	SELL	$189.21 - $243.2 $1,135 - $1,459	-6 Reduced 1.64%	360 $87,000
Q1 2019 Apr 30, 2019	BUY	$180.87 - $203.88 $66,198 - $74,620	366 New	366 $70,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.

Account